BioPharma & Healthcare Related News

Cellectis Patent Encompassing Broad Uses of Gene Editing Technologies Maintained by USPTO

May 10, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced that U.S. patent 8,921,332, which claims the use of chimeric restriction [...]

By | May 12th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Caribou Biosciences Announces Grant of a Key CRISPR-Cas9 Genome Editing Patent in Europe

BERKELEY, CA – May 10, 2017 – Caribou Biosciences, Inc., a leading genome engineering company, announced today that the European Patent Office (EPO) has granted a broad CRISPR-Cas9 genome editing patent to The Regents of the University of California, the [...]

By | May 12th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes

CAMBRIDGE, Mass. and BASEL, Switzerland, April 26, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA) and CRISPR Therapeutics AG (NASDAQ:CRSP), two leading genome editing companies focused on the development of potentially curative therapies, announced that the United States Patent and [...]

By | May 2nd, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Caribou Biosciences and DuPont Pioneer Develop New Method to Comprehensively Map the Off-Target Activity of CRISPR-Cas9 Across Entire Genomes

BERKELEY, Calif. and JOHNSTON, Iowa – May 1, 2017 – Caribou Biosciences, Inc., a leading company in CRISPR-Cas genome engineering, and DuPont Pioneer today announced the Nature Methods publication describing SITE-Seq, a new method for comprehensively mapping CRISPR-Cas9 cleavage sites [...]

By | May 2nd, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio

BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer [...]

By | April 18th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research

April 3, 2017 - WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer's [...]

By | April 4th, 2017|BioPharma & Healthcare, News, Press Releases|